Den Europæiske Union - dansk - EMA (European Medicines Agency)

amgen europe b.v. - carfilzomib - multipelt myelom - antineoplastiske midler - kyprolis in combination with daratumumab and dexamethasone, with lenalidomide and dexamethasone, or with dexamethasone alone is indicated for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

sanofi winthrop industrie - isatuximab - multipelt myelom - antineoplastiske midler - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - elotuzumab - multipelt myelom - antineoplastiske midler - empliciti er indiceret i kombination med lenalidomid og dexamethason til behandling af myelomatose hos voksne patienter, der har modtaget mindst én tidligere behandling (se afsnit 4. 2 og 5.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

oncopeptides ab - melphalan flufenamide hydrochloride - multipelt myelom - antineoplastiske midler - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

denk pharma gmbh & co kg - ezetimib - tabletter - 10 mg